Datroway: Data from P1 TROPION-Lung02 trial (NCT04526691) for advanced or metastatic NSCLC at ASCO (May 30-Jun 03, 2025) (Daiichi Sankyo) - May 7, 2025 - FY2024 Results: First data from rilvegostomig combo cohort of P1 TROPION-Lung04 trial (NCT04612751) for advanced or metastatic NSCLC at ASCO (May 30-Jun 03, 2025)
P1 data • Lung Cancer • Non Small Cell Lung Cancer • Oncology
|